CCA CATO Associate Protocol Development & Study Design 3

Question 1

What is the purpose of a feasibility assessment conducted before finalizing a clinical trial protocol?

Accepted Answer

To evaluate whether sites can enroll eligible participants and conduct the trial as designed

Answer

To verify that the protocol meets FDA formatting standards

Answer

To approve the informed consent document

Answer

To establish the statistical analysis plan

Question 2

In the context of protocol development, what is a 'stratification factor'?

Accepted Answer

A variable used to balance randomization across subgroups to reduce confounding

Answer

A criterion used to exclude participants from the study

Answer

A type of adverse event classification

Answer

A method of blinding site personnel

Question 3

Which document describes the preclinical and clinical data on an investigational product to guide safe use in a clinical trial?

Accepted Answer

Investigator Brochure

Answer

Case Report Form

Answer

Protocol Synopsis

Answer

Master File Index

Question 4

What is the 'intent-to-treat' (ITT) analysis population in a clinical trial?

Accepted Answer

All randomized participants analyzed in their assigned treatment group regardless of actual treatment received

Answer

Only participants who completed the full study per protocol

Answer

Only participants who received at least one dose of study drug

Answer

Participants who met all eligibility criteria without deviation

Question 5

Which risk is most directly mitigated by having a pre-specified Data Monitoring Committee (DMC) for an ongoing trial?

Accepted Answer

Risk of continuing a trial that is showing unexpected harm or clear benefit

Answer

Risk of protocol non-compliance at sites

Answer

Risk of incorrect randomization assignments

Answer

Risk of missing data in the case report forms

Question 6

What does the term 'protocol deviation' refer to in clinical trial operations?

Accepted Answer

Any departure from the approved protocol procedures or requirements

Answer

A change to the protocol submitted to the regulatory authority

Answer

The difference in efficacy outcomes between treatment arms

Answer

A failure to obtain informed consent prior to enrollment

Question 7

When finalizing a clinical trial protocol, which regulatory body in the United States must grant approval before an investigational drug can be used in human subjects?

Accepted Answer

Food and Drug Administration (FDA) via an IND application

Answer

NIH Office of Research Integrity

Answer

Centers for Disease Control and Prevention (CDC)

Answer

Department of Health and Human Services (HHS) Secretary